Skip to main content
LP

Levation Pharma, Ltd.

The startup develops a transdermal aqueous gel formulation of oxymetazoline for cosmetic eye lifts, specifically targeting ptosis or blepharoptosis. This product enables patients to elevate droopy upper eyelids, enhancing both their visual fields and the aesthetic appearance of their eyes.

Tel Aviv, Israel2100+ followers
Updated 2 months ago

Funding

$2.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Acquired blepharoptosis, or drooping upper eyelids, can reduce vision by narrowing the visual field and create an appearance of fatigue or aging. While blepharoplasty surgery is an option, many individuals seek non-surgical alternatives to improve both visual function and cosmetic appearance.

Solution

Levation Pharma is developing LEV-102, a proprietary, rapidly drying aqueous gel containing oxymetazoline for the treatment of acquired blepharoptosis. Applied topically to the upper eyelids once daily, LEV-102 is designed to penetrate the eyelid and stimulate Mueller's muscle, the involuntary "fight or flight" muscle responsible for elevating the upper lid. By inducing a slight contraction of this muscle, LEV-102 aims to lift the upper eyelid, thereby improving the visual field and rejuvenating the appearance of the eye. The odorless, colorless gel is formulated with stabilizers and permeation enhancers and can be used as an eyeshadow primer.

Target Audience

The primary target audience includes individuals with acquired blepharoptosis seeking a non-surgical treatment option to improve their visual field and/or the cosmetic appearance of their eyes.

Features

  • Proprietary aqueous gel formulation for topical application
  • Contains oxymetazoline, an active pharmaceutical ingredient with a history of FDA approval for other uses
  • Designed to selectively target and stimulate Mueller's muscle in the upper eyelid
  • Aims to improve visual fields and reduce the appearance of droopy eyelids
  • Odorless and colorless formulation that dries rapidly
  • Can be used as an eyeshadow primer
This profile is AI-generated and may contain inaccuracies.